| Model Number |
EVIVA 0913-12T |
| Medical Device Problem Code |
Failure to Obtain Sample (2533)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
02/09/2026
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
A device history record (dhr) review was conducted for the reported lot number.The device was released meeting all qa specifications.
|
| |
|
Event or Problem Description
|
|
It was reported that during an eviva breast biopsy procedure on (b)(6) 2026, the radiologist acquired eight core samples; however, only one sample was actually obtained.It is reported that very little tissue was acquired and no calcifications were present.The user site reports that the patient procedure was aborted.No further information is currently available.
|
| |
|
Additional Manufacturer Narrative
|
|
An investigation was conducted: it was reported that during an eviva breast biopsy procedure on (b)(6) 2026, the radiologist acquired eight core samples; however, only one sample was actually obtained.It is reported that very little tissue was acquired and no calcifications were present.The user site reports that the patient procedure was aborted.Investigation methods and findings: the device was not returned for this complaint.Investigation of this issue was conducted through customer-provided information, historical complaint review, analysis of similar events, and evaluation of product design.Cause/root cause: root cause analysis did not identify a definitive root cause.The investigation included a comprehensive review of complaint data and risk assessments, but could not perform any testing procedures, because the device was not returned.Conclusion: the root cause analysis did not identify a definitive cause.A thorough review of device history records, complaint data, risk assessments, and testing did not reveal a specific failure mode.Future events will be monitored and trended.Complaint confirmed: no.Device history record (dhr) review: the dhr for the corresponding lot was reviewed and, no manufacturing issues or relevant risk factors related to the analyzed failure mode were identified.
|
| |
|
Additional Manufacturer Narrative
|
|
The device has been returned to the manufacturer; therefore, a device investigation was conducted: it was reported that during an eviva breast biopsy procedure on (b)(6) 2026, the radiologist acquired eight core samples; however, only one sample was actually obtained.It is reported that very little tissue was acquired and no calcifications were present.The user site reports that the patient procedure was aborted.Initial evaluation: the returned unit was investigated on april 9th, 2026.The device arrived visibly used.Investigation methods and findings: visual inspection was performed and it was noted that the entire tubing quadset was cut; therefore, functional testing could not be performed.Based on the condition in which the device was received, the complaint could not be confirmed.This observation will be monitored and trended.Cause/root cause: the cause of the complaint cannot be determined based on the available evidence.Conclusion: based on the evaluation performed, the issue could not be confirmed since it was not possible to perform the functional test due to the conditions of the returned device.The cause of the complaint could not be established with the available evidence.There is no capa/scar/hra/hhe/nce related to the reported problem and based on risk analysis, there is no need for capa/scar/hra/hhe/nce escalation due to the reported problem.There is no quality events associated with the reported issue.Future events will be monitored and trended.Complaint confirmed: no.Device history record (dhr) review: dhr review was conducted for eviva finished good lot.The device was released meeting all qa specifications.
|
| |
|
Search Alerts/Recalls
|